Health
Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
By Marcus Chen
MarketWatch
Advertisement

Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations